C83.3 C88.0
Conditions
Interventions
Group 1: Non-interventional patient registry with prospective and retrospective data collection. All patients diagnosed with malignant lymphoma can participate (exceptions see inclusion criteria). Pat
Sponsors
German Lymphoma Alliance (GLA) e.V.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Malignant lymphoma (except for Hodgkin’s disease (MH) without concomitant HIV infection, multiple myeloma (MM) and chronic lymphocytic leukemia (CLL)) or related lymphoproliferative disease e.g. Castleman’s disease 2. Informed consent
Exclusion criteria
Exclusion criteria: There are no exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Understand the course of disease of different malignant lymphoma entities. Understand the results and impact of specific treatment methods. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Understand scope of responses to sequentially applied treatments • Collect real world data on treatments used • Collect real world data on progression free survival • Collect real world data on overall survival • Collect real world data on healthcare resource utilization (project-specific) • Develop prediction model for selection of drugs • Analysis of treatment schedule algorithms • Long-term follow-up of clinical trials • Analyze treatment specific adverse events (project-specific) • Evaluation of prognostic scoring system in the population of subpopulations • Evaluation of impact of comorbidity scores on outcome • Evaluation of Quality of Life (project-specific) | — |
Countries
Germany
Contacts
Public ContactAnke Ohler
Universitätsmedizin der Johannes Gutenberg-Universität
Outcome results
None listed